Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Spexib 150 mg Capsule
Manufacturer/Marketed By : Sandoz Private Limited
$98.57 $94.84
Sidmex Inovia offers bulk export supply of Spexib 150 mg Capsule (Ceritinib 150 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Ceritinib 150 mg
Active Pharmaceutical Ingredient
Spexib 150 mg Capsule
$98.57
$94.84
Sidmex Inovia offers bulk export supply of Spexib 150 mg Capsule (Ceritinib 150 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Spexib 150 mg capsule is an effective treatment option classified as an anaplastic lymphoma kinase (ALK) inhibitor, specifically designed for adult patients facing advanced non-small cell lung cancer (NSCLC) that tests positive for ALK. As a first-line therapy, Spexib works by targeting and blocking the activity of the ALK protein, which plays a crucial role in cancer cell growth and proliferation. This targeted approach can help slow down the progression of the disease, offering hope to those affected by this challenging condition. It is important to note that Spexib is not suitable for individuals under 18 years of age, as its safety and effectiveness in this population have not been established. Additionally, elderly patients, particularly those aged 65 and above, should use this medication with caution and under the guidance of their healthcare provider. Always consult your doctor before starting treatment to discuss any potential risks and benefits associated with Spexib. This comprehensive understanding of the drug's indications and precautions ensures patients receive informed and tailored care in their cancer treatment journey.
Active Pharmaceutical Ingredient
Uses
• Spexib 150 mg capsule is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). This medication targets specific cancer cells, helping to inhibit their growth and proliferation. Patients with advanced or metastatic NSCLC may benefit significantly from Spexib 150 mg capsule. Its use is tailored to improve outcomes in individuals facing this challenging diagnosis.
• In cases where traditional therapies are less effective, Spexib 150 mg capsule offers an alternative approach for managing non-small cell lung cancer. It works by interfering with the cancer cell signaling pathways, which can lead to improved disease control. Healthcare providers may prescribe Spexib 150 mg capsule when other treatment options have been exhausted. This allows for a more personalized treatment strategy.
• Spexib 150 mg capsule is often utilized in combination with other cancer treatments to enhance therapeutic efficacy. Oncologists may recommend this medication as part of a comprehensive treatment plan for patients with NSCLC. By incorporating Spexib 150 mg capsule, the aim is to maximize the potential for tumor reduction. This collaborative approach can lead to better management of the disease.
• Patients with non-small cell lung cancer may also receive Spexib 150 mg capsule as a maintenance therapy after initial treatment. This strategy helps in prolonging the time without disease progression. By continuing Spexib 150 mg capsule, patients can maintain quality of life while managing their cancer effectively. Regular monitoring and follow-up are essential to assess the ongoing benefits of this therapy.
Benefits
Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Spexib 150 mg Capsule helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Spexib 150 mg Capsule can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Heartburn
• Constipation
• Nausea
• Vomiting
• Diarrhoea
• Abdominal pain
• Loss of appetite
• Fever
• Rashes
• Itching
• Hyperglycemia ( increased sugar)
• Fainting
• Seizure
Common Side Effects
• Liver problems ( Nausea/ Vomiting)
• Tingling/ Numbness
• Abdominal pain
• Yellowish skin and eyes
• Dark urine
• Blurred vision
• Decreased vision
• Generalized weakness
• Trouble Breathing
• Difficulty in breathing
How To Use
Spexib 150 mg Capsule should be taken orally once daily with food at the same time every day. Spexib 150 mg should be swallowed whole with water. The capsules should not be chewed or crushed. If a dose is missed, the patient should make up that dose, unless the next dose is due within 12 hours. If vomiting occurs during the course of treatment, the patient should not take an additional dose but should continue with the next scheduled dose. Your doctor will decide on dosage and frequency as per your disease condition and several other factors.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Spexib 150 mg. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Spexib 150 mg Capsule. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Spexib 150 mg Capsule is considered to be safe for use in mild to moderate kidney disease patients. No dose adjustment is necessary in patients with mild to moderate kidney disease patients. Caution should be used in patients with severe kidney disease patients.
• Breastfeeding: It is not recommended to breastfeed while taking Spexib 150 mg Capsule. Spexib 150 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Spexib 150 mg Capsule, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Spexib 150 mg Capsule is considered to be safe for use in mild to moderate liver disease patients. No dose adjustment is necessary in patients with mild to moderate liver disease patients. For patients with severe liver disease (Child-Pugh C), reduce the dose of Spexib 150 mg.
• Pregnancy: Use of Spexib 150 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Ceritinib Capsule 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Spexib 150 mg Capsule may cause blurred vision, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.